Therapeutic Areas: Oncology | Dermatology | Family Medicine

Metastatic Melanoma Clinical Trials


A listing of Metastatic Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

Patients are needed to participate in a clinical research study evaluating CDX-1127

Scottsdale : Call for Information (Investigational Site 0004) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Tucson : The University of Arizona Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Tucson : University Arizona Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Tucson : The University of Arizona Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

California

Beverly Hills : Call for Information (Investigational Site 0027) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Encinitas : Call for Information (Investigational Site 0030) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Fresno : Call for Information (Investigational Site 0135) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

La Jolla : Moores UCSD Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Los Angeles : USC Norris Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Los Angeles :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Los Angeles : Call for Information (Investigational Site 0015) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Los Angeles : Call for Information (Investigational Site 0010) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

San Francisco : Call for Information (Investigational Site 0008) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Colorado

Aurora : University of Colorado Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Connecticut

New Haven : Smilow Cancer Hospital at Yale New Haven

A clinical trial to evaluate treatments using Vemurafenib for patients with Melanoma [C04.557.465.625.650.510]

New Haven : Call for Information (Investigational Site 0028) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

District of Columbia

Washington : Georgetown University Medical Center Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Washington Cancer Institute at MedStar Washington Hospital Center Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Florida

Jacksonville : Call for Information (Investigational Site 0003) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Miami :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Miami Beach : Mount Sinai Medical Center Comprehensive Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Miami Beach : MSMC Research Program

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Miami Beach : MSMC Research Program

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Tampa :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study for the treatment of Metastatic Melanoma

Georgia

Savannah : Memorial University Medical Center

Alliance/NCCTG N0879: A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma

Atlanta : Emory University Winship Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Atlanta : Emory University School of Medicine

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Atlanta : Call for Information (Investigational Site 0026) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Illinois

Chicago :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Maywood : Loyola University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Maywood : Loyola University Medical Center, Div of Hematology/Oncology

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Park Ridge : Oncology Specialists, SC

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Park Ridge : Luther General Cancer Care Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Park Ridge : Oncology Specialists, SC

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Indiana

Indianapolis : Indiana University Melvin and Bren Simon Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Indianapolis : Indiana University

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Iowa

Iowa City : University of Iowa Hospitals and Clinics

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals & Clinics

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study evaluating Temozolomide, Decitabine, Panobinostat for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals & Clinics

Patients are needed to participate in a clinical research study evaluating Vemurafenib, Decitabine for the treatment of Metastatic Melanoma, Melanoma, BRAF-mutated Metastatic Melanoma or V600EBRAF-mutated Metastatic Melanoma

Kansas

Kansas City : University of Kansas Hospital

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Louisiana

Baton Rouge : The Baton Rouge Clinic, AMC

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Baton Rouge : Hematology/Oncology Clinic

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Maryland

Baltimore : Harry and Jeannette Weinberg Cancer Institute at Franklin Square Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Lutherville : Johns Hopkins

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Lutherville : Johns Hopkins Medicine

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Massachusetts

Boston : Beth Israel Deaconess Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Boston : Beth Israel Deaconess Medical Center (BIDMC) Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Dana-Farber Cancer Institute Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Call for Information (Investigational Site 0011) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Michigan

Ann Arbor : University of Michigan Health System

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Ann Arbor : University of Michigan, Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Detroit : Barbara Ann Karmanos Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Detroit : Karmanos Cancer Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Detroit : Karmanos Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Minnesota

Minneapolis : University of Minnesota Masonic Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Minneapolis : University of Minnesota Masonic Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Rochester : Call for Information (Investigational Site 0002) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Missouri

St. Louis : Saint Louis University Cancer Cener

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Nebraska

Omaha : Midwest Cancer Center - Legacy

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Omaha : Nebraska Cancer Specialists, Midwest Cancer Center - Legacy

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

New Hampshire

Lebanon : Dartmouth Hitchcock Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Lebanon : Dartmouth-Hitchcock Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New Jersey

Hackensack : Hackensack University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New York

New York : Saint Luke's-Roosevelt Hospital Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

New York : Columbia University/Herbert Irving Comprehensive Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Ctr

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

New York : NYU Langone Medical Center Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : NYU Clinical Cancer Center Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : Call for Information (Investigational Site 0019) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

North Carolina

Charlotte : Blumenthal Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Durham : Duke University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Durham :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Durham : Duke University Health System

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Winston-Salem : Wake Forest University Baptist Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Ohio

Cincinnati : The Christ Hospital Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Cincinnati : The Christ Hospital Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Cincinnati : The Christ Hospital

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Cleveland : University Hospitals Siedman Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Cleveland : Case Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Oregon

Portland : Providence Portland Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Portland : Providence Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Portland : Providence Portland Medical Center

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Portland : Providence Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Portland : Providence Portland Medical Center New

A Phase 1 clinical study for patients with Metastatic Melanoma

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Pennsylvania

Bethlehem : Saint Luke's Hospital and Health Network

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Easton : St. Luke's Hospital, Anderson Campus

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Philadelphia :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Philadelphia : Fox Chase Cancer Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Philadelphia : Call for Information (Investigational Site 0029) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Philadelphia : Call for Information (Investigational Site 0016) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Pittsburgh : Hillman Cancer Research Pavilion, Div. of Medical Oncology

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Pittsburgh : UPMC Cancer Centers

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Pittsburgh : University of Pittsburgh Medical Center Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Pittsburgh : Call for Information (Investigational Site 0013) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Tennessee

Knoxville : University of Tennessee Medical Center

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Nashville : Vanderbilt-Ingram Cancer Ctr

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : Vanderbilt-Ingram Cancer Center Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Nashville : Call for Information (Investigational Site 0134) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Texas

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Houston : MD Anderson Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Houston : UT MD Anderson Cancer Center

A clinical research study of LOC-paclitaxel for the treatment of Melanoma

Houston : The University Of Texas Md Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Houston : MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Houston : UT MD Anderson Cancer Center Updated

A clinical trial to evaluate treatments using HDIL-2 and recMAGE-A3 + AS15 for patients with Melanoma

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using investigational drug INGN 241 for patients with Malignant Melanoma or Neoplasm Metastasis

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Melanoma

Houston : Call for Information (Investigational Site 0012) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Houston : UT MD Andreson Cancer Center Updated

Patients are needed to participate in a clinical research study of GSK2118436 and GSK1120212 to evaluate Melanoma

San Antonio : The START Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

San Antonio : Call for Information (Investigational Site 0001) Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Utah

Salt Lake City : Huntsman Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Virginia

Charlottesville : University of Virginia Health System

Patients are needed to participate in a clinical research study evaluating CDX-1127

Washington

Seattle : University of Washington Medical Center Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : Seattle Cancer Care Alliance Updated

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Wisconsin

Franklin : Wheaton Franciscan Cancer Care

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Australia

Heidelberg : Austin Health, LICR Melbourne Austin Branch

A clinical research study of Bacillus Calmette-Guérin (BCG) vaccine and Ipilimumab for the treatment of Metastatic Melanoma

North Ryde : Merck Sharp & Dohme Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Belgium

Brussels : Cliniques universitaires Saint-Luc, Centre du Cancer

A Phase 1/Phase 2 clinical study for patients with Melanoma

Canada

Edmonton : Cross Cancer Institute

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Hamilton : Juravinski Cancer Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Kirkland : Merck Canada Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

London : London Health Sciences Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

France

Marseille : Hôpital Sainte Marguerite

Patients are needed to participate in a clinical research study evaluating masitinib and Dacarbazine for the treatment of Metastatic Melanoma

Paris : MSD France Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Italy

Milan : Fondazione IRCCS Istituto Nazionale dei Tumori

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Padova : Vanna Chiarion-Sileni, MD

A clinical trial to evaluate treatments using Anti-B-RAF for patients with Metastatic Melanoma

Rome : MSD Italia S.r.l. Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Siena : Azienda Ospedaliera Universitaria Senese

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Korea, Republic of

Seoul : MSD Korea LTD Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Spain

Madrid : Merck Sharp and Dohme de Espana S.A. Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Pamplona : Local Institution

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

United Kingdom

Cambridge : Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital)

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Hoddesdon : Merck Sharp & Dohme Ltd. Updated

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

London : The Royal Marsden Hospital

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Manchester : The Christie NHS Foundation Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Newcastle upon Tyne : Newcastle upon Tyne Hospitals

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Oxford : Oxford University Hospitals NHS Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor